2021
Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs
ANDRAŠINA, Tomáš, Jaroslav JURÁČEK, Jan ZAVADIL, Barbora ČECHOVÁ, Tomáš ROHAN et. al.Základní údaje
Originální název
Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs
Autoři
ANDRAŠINA, Tomáš (703 Slovensko, garant, domácí), Jaroslav JURÁČEK (203 Česká republika, domácí), Jan ZAVADIL (203 Česká republika, domácí), Barbora ČECHOVÁ (203 Česká republika, domácí), Tomáš ROHAN (203 Česká republika, domácí), Petra VESELÁ (203 Česká republika, domácí), Mor PALDOR, Ondřej SLABÝ (203 Česká republika, domácí) a Nahum GOLDBERG
Vydání
Journal of vascular and interventional radiology, New York, Lippincott Williams & Wilkins, 2021, 1051-0443
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30224 Radiology, nuclear medicine and medical imaging
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.682
Kód RIV
RIV/00216224:14110/21:00121875
Organizační jednotka
Lékařská fakulta
UT WoS
000645600200011
Klíčová slova anglicky
EPITHELIAL-MESENCHYMAL TRANSITION; RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; SERUM MICRORNA-210; CANCER; EXPRESSION; MECHANISM; GROWTH; PROGRESSION; METASTASIS
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 8. 2024 08:12, Mgr. Tereza Miškechová
Anotace
V originále
Purpose: To determine whether the levels of circulating microRNAs (miRNAs) are altered in patients undergoing thermal ablation and chemoembolization and whether these changes are predictive of a clinical outcome. Material and Methods: This prospective study consisted of 43 patients diagnosed with hepatocellular carcinoma (n = 15) and intrahepatic colorectal cancer metastases (n = 28) treated with thermal ablation (n = 23; radiofrequency [n = 6] or microwave [n = 19]), chemoembolization using drug-eluting embolics (n = 18), or both (n = 2). Four blood samples (immediately before the intervention and 60-90 minutes, 24 hours, and 7 days after the intervention) were taken to measure the plasma concentrations of miRNAs related to hypoxia (miR-21 and miR-210), liver injury (miR-122), epithelial-mesenchymal transition (miR-200a), and apoptosis (miR-34a) using miRNA-specific TaqMan assays and quantitative real-time polymerase chain reaction. Tumor burden and treatment response at 3 months were evaluated using the modified response evaluation criteria in solid tumors. The miRNA results were compared with clinical outcomes (Mann-Whitney U test, Wilcoxon matched-pair test). Results: Dynamic changes in the circulating miRNA levels were observed following both the interventions. For thermal ablation, significant increases in miR-21, miR-210, miR-122, miR-200a, and miR-34a concentrations peaked 60-90 minutes after the intervention (P < .01). However, for transarterial chemoembolization, maximum increases in the miRNA concentrations were observed at 24 hours after the intervention for miR-21, miR-210, miR-122, miR-200a, and miR-34a (P < .05). The increased concentrations of the circulating miRNAs were followed by a subsequent decline to baseline by 7 days. For the thermal ablation (but not chemoembolization) patients, elevations in the miR-210 and miR-200a levels were associated with early progressive disease at 3 months (P = .040 and P = .012, respectively). Conclusions: Increased but dynamic levels of circulating miRNAs are present following interventional oncologic procedures and may prove useful as biomarkers for the monitoring of clinical outcomes.
Návaznosti
MUNI/A/1488/2019, interní kód MU |
|